We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pharma Investor Says $180M Deal Proxy Lacks Key Info

Law360 (January 18, 2019, 8:04 PM EST) -- A shareholder of intravenous pain medication developer Avenue Therapeutics Inc. filed suit in Delaware federal court Thursday against the company’s directors alleging a proxy statement describing a $180 million acquisition of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Delaware

Nature of Suit

Securities/Commodities

Judge

Subscribers Only

Date Filed

January 17, 2019

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.